Cuprina Holdings (Cayman) Limited (CUPR)
NASDAQ: CUPR · Real-Time Price · USD
0.3635
-0.0096 (-2.59%)
Mar 16, 2026, 3:19 PM EDT - Market open

Revenue by Segment

Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Maggot Debridement Therapy Product
34.42K78.96K56.60K58.50K
Maggot Debridement Therapy Product Growth
-56.41%39.50%-3.26%-
Cosmeceutical Product
13.90K21.82K--
Cosmeceutical Product Growth
-36.27%---
Total
48.32K100.77K56.60K58.50K
Total Growth
-52.05%78.05%-3.26%-

Revenue by Geography

Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Singapore
48.32K100.77K56.60K58.50K
Singapore Growth
-52.05%78.05%-3.26%-
Total
48.32K100.77K56.60K58.50K
Total Growth
-52.05%78.05%-3.26%-
Source: S&P Global Market Intelligence.